Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 1,000 shares of the stock in a transaction that occurred on Friday, October 9th. The shares were sold at an average price of $25.84, for a total transaction of $25,840.00. Following the sale, the chief executive officer directly owned 184,952 shares of the company’s stock, valued at approximately $4,779,159.68. This represents a 0.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Margaret Tooth also recently made the following trade(s):
- On Friday, September 11th, Margaret Tooth sold 1,000 shares of Trupanion stock. The stock was sold at an average price of $25.00, for a total transaction of $25,000.00.
- On Tuesday, August 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $31.84, for a total transaction of $15,633.44.
- On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The shares were sold at an average price of $29.05, for a total value of $28,410.90.
Trupanion Price Performance
Shares of NASDAQ TRUP traded up $0.28 during trading on Tuesday, hitting $26.57. The company had a trading volume of 273,520 shares, compared to its average volume of 440,041. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $46.98. The business’s 50-day moving average is $26.95 and its 200 day moving average is $25.51. The company has a market cap of $1.17 billion, a P/E ratio of 50.13, a PEG ratio of 1.80 and a beta of 1.44. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the company. Weiss Ratings raised Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, September 29th. Atlantic Securities set a $42.00 price target on Trupanion in a research note on Wednesday, July 15th. Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. Piper Sandler downgraded Trupanion from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $45.00 to $32.00 in a report on Wednesday, August 26th. Finally, Stifel Nicolaus upped their price objective on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research note on Thursday, August 20th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $38.40.
Check Out Our Latest Research Report on Trupanion
Hedge Funds Weigh In On Trupanion
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TRUP. Bank of New York Mellon Corp acquired a new position in shares of Trupanion in the 2nd quarter valued at about $4,631,000. Bank of America Corp DE purchased a new stake in shares of Trupanion in the second quarter worth approximately $14,262,000. Renaissancere Holdings Ltd. purchased a new stake in shares of Trupanion in the second quarter worth approximately $6,514,510. GSA Capital Partners LLP acquired a new stake in shares of Trupanion during the second quarter worth approximately $1,394,000. Finally, Legal & General Group Plc acquired a new stake in shares of Trupanion during the second quarter worth approximately $1,938,000.
About Trupanion
Trupanion, Inc is a pet insurance company that provides medical insurance for cats and dogs. Its coverage is designed to help pet owners manage eligible veterinary expenses, including treatment for accidents, illnesses and other covered medical conditions.
The company offers subscription-based insurance plans primarily through direct-to-consumer channels and partnerships with veterinary practices. Trupanion also provides tools intended to streamline claims processing and enable participating veterinarians to receive payments directly, reducing the need for pet owners to pay eligible costs upfront and seek reimbursement.
Founded in 2000, Trupanion is headquartered in Seattle, Washington.
Featured Articles
- Five stocks we like better than Trupanion
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
